Investigation the effectiveness and non effectiveness of inhaled salbutamol in the treatment of respiratory diseases
Phase 2
- Conditions
- Transient tachypnoea of newborn.Transient tachypnoea of newborn
- Registration Number
- IRCT2017081414333N80
- Lead Sponsor
- Vice chancellor for research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Neonates with term of gestational age; Near term or after term; Having clinical symptoms and biographies in favor of TTN diagnosis; Having at least one of the radiographic TTN criteria (including hyperinflation, the presence of fluid in the transverse Fisher, etc).
Exclusion criteria: Meconium aspiration history; Respiratory distress syndrome; Congenital pneumonia; Polycysthemia; Hypoglycemia; Prolonged early sepsis; Cardiovascular disease; Tachycardia greater than 180 beats per minute; Cardiac arrhythmia; Congenital anomaly
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of breaths. Timepoint: Before starting treatment and after treatment at intervals: 30 minutes, one and four hours after the start. Method of measurement: By physician based on the number of breaths per minute.;Percent saturation of oxygen. Timepoint: Before starting treatment and after treatment at intervals: 30 minutes, one and four hours after the start. Method of measurement: By pulse oximetry.;Heart rate. Timepoint: Before starting treatment and after treatment at intervals: 30 minutes, one and four hours after the start. Method of measurement: By pulse oximetry.
- Secondary Outcome Measures
Name Time Method